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3) PEPT1 is primarily expressed in apical membrane of small intestinal epithelial cells. 4) PEPT1 is thought to be involved in gastrointestinal absorption of its substrates. Involvement of PEPT1 may explain the difference in bioavailability between valacyclovir (PEPT1 substrate) and acyclovir (non-substrate) in humans. 5, 6) We have recently reported that rab8-null mice, which exhibit minimal expression of PEPT1 on apical membranes of small intestine, lack saturable uptake of a prototypical PEPT1 substrate glycylsarcosine (Gly-Sar). 7) This may indicate a predominant role of PEPT1 in the peptide absorption. In addition to small intestine, PEPT1 is functionally expressed in some human cancer cell lines [8] [9] [10] and therefore would be a promising target for tumor detection. Indeed, a positron emitting probe targeted to PEPT1, 11 C-glycylsarcosine, was recently demonstrated to be able to distinguish between tumor and inflamed tissues.
11)
The b-lactam antibiotic cephalexin ((6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; D-cephalexin) is a typical substrate of PEPT1. [12] [13] [14] This D-cephalexin is now clinically used for chemotherapy. PEPT1 is presumably responsible for membrane permeation of D-cephalexin in small intestine, because small intestinal uptake of D-cephalexin assessed with an everted sac method was greatly reduced in rab8-null mice.
15) The L-diastereomer of cephalexin (Lcephalexin) is also probably transported by PEPT1 in Caco-2 cells. 16) However, intact L-cephalexin was not found in vesicles or proteoliposomes prepared from brush border membrane of intestinal epithelial cells. 17) Although, L-cephalexin was not detected, and the hydrolysis product, 7-aminodesacetoxycephalosporanic acid (7-ADCA), appeared very rapidly in serum and urine after oral administration in rats. 18) This observation suggests that L-cephalexin can be absorbed from gastrointestinal tract. However, there has been no direct demonstration that L-cephalexin is transported by PEPT1 protein.
We recently proposed that orally administered Lcephalexin might be transported and metabolized by PEPT1. 13) Indeed, hydrolysis of L-cephalexin was markedly increased by exogenous transfection of PEPT1 gene into cultured cell lines, and metabolism of cephalexin was observed even in membrane-permeabilized cells expressing PEPT1, in which intracellular accumulation of L-cephalexin was negligible. 13) This observation may imply that L-cephalexin hydrolysis is mediated by PEPT1 itself, although possible involvement of endogenous peptidases cannot be excluded, because these experimental systems utilized mammalian cells.
The purpose of the present study was to clarify whether or not PEPT1 transports and/or metabolizes L-cephalexin. We performed L-cephalexin metabolism and uptake experiments using a highly purified PETP1 protein-expressing system, budded baculovirus 19) which lacks endogenous mammalian metabolic enzymes. Preparation of Budded Baculovirus The budded baculovirus fraction was prepared as reported previously 19) from the supernatant after 72-h or 96-h infection at MOI 5 or 1 for the PEPT1-expressing or wild-type system, respectively. Protein concentration was determined by DC Protein Assay Reagent (Bio-Rad, Hercules, CA, U.S.A.) using bovine serum albumin as a standard.
MATERIALS AND METHODS

Materials
Metabolism Assay The reaction (37°C) was initiated by adding L-cephalexin to baculovirus (50 mg protein) suspended in assay buffer to give a final concentration of 1 mM. The assay buffer was 25 mM MES/Tris (ՅpH 6.5) or HEPES/Tris (ϾpH 6.5) containing (mM) NaCl (140), KCl (5.4), CaCl 2 (1.8), MgCl 2 (0.8), and D-glucose (5) . The reaction was terminated by adding ice-cold acetonitrile containing 10 mM cefslodine (Sigma-Aldrich) as an internal standard.
Uptake Assay Uptake was assessed by a rapid filtration technique as described previously 19) in the assay buffer containing budded baculovirus (50 mg protein) and 1 mM Lcephalexin at 37°C.
Quantification of 7-ADCA and L-Cephalexin The HPLC system used for quantification of 7-ADCA and Lcephalexin was previously described. 13) Hydrophilic Interaction Chromatography (HILIC) packed column, COSMOSIL HILIC 4.6 mm I.D.ϫ250 mm (Nacalai Tesque, Inc., Kyoto Japan) was used as an analytical column, and the UV detector was set at 260 nm. The mobile phase was 10 mM ammonium acetate/acetonitril (30 : 70, v/v). The flow rate was 1.0 ml/min. The limits of quantification for 7-ADCA and Lcephalexin were 0.3 and 0.2 ng/ml, and the calibration curves were linear from 0.3 to 20 (R 2 ϭ0.995) and from 0.2 to 30 ng/ml (R 2 ϭ0.997), respectively. Membrane Potential Assay Measurements of membrane potentials were performed as previously described 20) using a FlexStation II (Nihon Molecular Devices, Osaka, Japan). Membrane potential changes were tracked with a voltage-sensitive fluorescent indicator, membrane potential assay kit, blue (Nihon Molecular Devices). The dye solution reconstituted in HBSS (60 ml) was first added to wells, and mixed with the cells and incubated for 30-60 min at 37°C. Assays were then carried out at 37°C and were initiated by the addition of 60 ml of test compound. Fluorescence was measured every 2 s for 120 s, using wavelengths of 530 (excitation) and 565 nm (emission). Raw fluorescence data were analyzed with SoftMax Pro 5.0.1 (Nihon Molecular Devices). The EC 50 values (concentration at half-maximum fluorescence response) were obtained using KaleidaGraph (Synergy Software, Reading, PA, U.S.A.) by fitting the data to a four-parameter logistic, in which the baseline response (Fl base ), the maximum response (Fl max ), the slope (S), and 
RESULTS AND DISCUSSION
To verify whether L-cephalexin is transported and hydrolyzed by PEPT1, we used budded baculovirus expressing only PEPT1 protein and viral envelope protein gp64, the major coat protein of the budded virion. 19) Whether or not Lcephalexin is transported by PEPT1 has been controversial. One group reported that L-cephalexin was not transported by peptide transporter(s), 17) whereas another group observed substrate-induced intracellular acidification caused by transport of L-cephalexin via a peptide transporter, possibly PEPT1, though they did not detect L-cephalexin itself.
16) L-
Cephalexin was not detected in membrane vesicles, proteoliposomes or intact cell lines endogenously or exogenously expressing PEPT1. 13, 16, 17) These observations and the fact that a metabolite of L-cephalexin, 7-ADCA, was detected immediately after oral dosing 18) imply that PEPT1 itself may mediate L-cephalexin hydrolysis, although to date, only we 13) have suggested that hydrolytic enzyme activity may be associated with PEPT1. In the present study using budded baculovirus, which expresses PEPT1, but not any endogenous mammalian enzyme, PEPT1-mediated transport of L-cephalexin was clearly observed, since substantial amount of intact Lcephalexin was detected in PEPT1-expressing budded baculovirus (Fig. 1A) . The uptake of L-cephalexin by wild-type virus was much smaller (Fig. 1A) . The formation of 7-ADCA in wild-type virus was below the detection limit, suggesting that hydrolase contamination in the virus was minimal. The uptake of L-cephalexin in PEPT1-expressing budded baculovirus was higher at pH 6.0 than at pH 7.4 (Fig.  1B) , suggesting that L-cephalexin transport may be protondriven. The uptake of L-cephalexin in the presence of Dcephalexin (5 mM), or the prototypical PEPT1 substrate glycylsarcosine (20 mM) or the non-substrate amino acid glycine (20 mM) , assessed at 37°C and pH of 6.0, amounted to 3.02Ϯ0.24, 1.09Ϯ0.13% and 86.0Ϯ7.3% of the control, respectively (meanϮS.E., nϭ3). Thus, the uptake of Lcephalexin was markedly inhibited by D-cephalexin and gly-Vol. 32, No. 8 cylsarcosine, but not glycine. These findings indicate that Lcephalexin is indeed transported by PEPT1. To examine the affinity of L-cephalexin for PEPT1, we carried out membrane potential assay using FlexStation II in HeLa cells stably expressing PEPT1, because this methodology is more sensitive than the detection of uptake by means of HPLC-UV. Upon PEPT1 activation with L-cephalexin, dose-dependent membrane depolarization was observed with an EC 50 of 178Ϯ32 mM (Fig. 2) . Because the EC 50 of D-cephalexin (2.87Ϯ3.15 mM) was much larger than that of L-cephalexin, it is clear that L-cephalexin, which resembles natural dipeptides (L-isoform), has much higher affinity for PEPT1 than dose Dcephalexin.
We next examined the metabolic activity of PEPT1 using the same budded virus. Unexpectedly, 7-ADCA, a metabolite of L-cephalexin, was not detected in PEPT1-expressing budded virus or wild-type virus at pH 6.0 or 7.4 during incubation for up to 120 min (Յ0.015 pmol/mg protein/min). The limit of quantification for 7-ADCA was similar to that for Lcephalexin (see Materials and Methods). Nevertheless, strong L-cephalexin uptake was detected (Fig. 1) , whereas formation of 7-ADCA was below detection limit. Thus, it can be concluded that L-cephalexin is not hydrolyzed by PEPT1 alone. However, the present finding does not exclude the possibility that PEPT1 itself can hydrolyze L-cephalexin, but requires additional cofactor(s). In addition, it has recently been demonstrated in mouse small intestine that PEPT1 physically interacts with PDZ (PSD95/Dlg/ZO1) domaincontaining scaffold protein PDZK1, which increases the transport activity of PEPT1 and other solute carrier transporters. 21, 22) PDZK1 interacts with various intracellular and membranous proteins which have the so-called PDZ interacting motif at their extreme carboxyl terminus. 21) Therefore, it is considered that in in vivo and in vitro cultured cell lines, PEPT1 protein may be strongly linked with endogenous hydrolase(s) via such a scaffold protein like PDZK1, and diand tripeptides taken up by PEPT1 would be efficiently hydrolyzed by this enzyme.
In conclusion, L-cephalexin is transported more effectively than D-cephalexin by PEPT1, but is not metabolized by PEPT1 alone. The present findings imply that drug design to improve gastrointestinal absorption via PEPT1 may also be applicable with a prodrug strategy to deliver active metabolites into the systemic circulation. The peak fluorescence intensity normalized to the baseline was plotted against concentration of L-(᭹) or D-cephalexin (᭺). Data were fitted to a four-parameter nonlinear dose-response curve with four parameters. Each point represents the meanϮS.E. (nϭ3).
